Literature DB >> 9399891

Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.

L B Jacoby1, D Jones, K Davis, D Kronn, M P Short, J Gusella, M MacCollin.   

Abstract

Patients with multiple schwannomas without vestibular schwannomas have been postulated to compose a distinct subclass of neurofibromatosis (NF), termed "schwannomatosis." To compare the molecular-genetic basis of schwannomatosis with NF2, we examined the NF2 locus in 20 unrelated schwannomatosis patients and their affected relatives. Tumors from these patients frequently harbored typical truncating mutations of the NF2 gene and loss of heterozygosity of the surrounding region of chromosome 22. Surprisingly, unlike patients with NF2, no heterozygous NF2-gene changes were seen in normal tissues. Examination of multiple tumors from the same patient revealed that some schwannomatosis patients are somatic mosaics for NF2-gene changes. By contrast, other individuals, particularly those with a positive family history, appear to have an inherited predisposition to formation of tumors that carry somatic alterations of the NF2 gene. Further work is needed to define the pathogenetics of this unusual disease mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399891      PMCID: PMC1716092          DOI: 10.1086/301633

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

2.  Congenital neurilemmomatosis.

Authors:  T Sasaki; H Nakajima
Journal:  J Am Acad Dermatol       Date:  1992-05       Impact factor: 11.527

3.  Agminated neurilemomas.

Authors:  T G Berger; N A Lapins; M L Engel
Journal:  J Am Acad Dermatol       Date:  1987-11       Impact factor: 11.527

4.  Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

Authors:  M A Anderson; J F Gusella
Journal:  In Vitro       Date:  1984-11

5.  Multifocal neurilemmomas of median and ulnar nerves of the same extremity--case report.

Authors:  R C Lewis; L H Nannini; W M Cocke
Journal:  J Hand Surg Am       Date:  1981-07       Impact factor: 2.230

6.  The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2.

Authors:  M I Kaiser-Kupfer; V Freidlin; M B Datiles; P A Edwards; J L Sherman; D Parry; L M McCain; R Eldridge
Journal:  Arch Ophthalmol       Date:  1989-04

7.  Multiple cutaneous neurilemmomas as a skin manifestation of neurilemmomatosis.

Authors:  T Shishiba; M Niimura; F Ohtsuka; N Tsuru
Journal:  J Am Acad Dermatol       Date:  1984-05       Impact factor: 11.527

Review 8.  Localized multiple neurilemmomas of the lower extremity.

Authors:  K M Buenger; N C Porter; S E Dozier; R F Wagner
Journal:  Cutis       Date:  1993-01

9.  Schwannomatosis. An unusual variant of neurofibromatosis or a distinct clinical entity?

Authors:  S M Purcell; S L Dixon
Journal:  Arch Dermatol       Date:  1989-03

10.  A clinical study of type 2 neurofibromatosis.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; R Harris
Journal:  Q J Med       Date:  1992-08
View more
  40 in total

Review 1.  Neurology and the skin.

Authors:  O Hurko; T T Provost
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

Review 2.  Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature.

Authors:  Ana-Maria Vranceanu; Vanessa L Merker; Elyse R Park; Scott R Plotkin
Journal:  J Neurooncol       Date:  2015-02-07       Impact factor: 4.130

3.  The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.

Authors:  Anne-Marie Bashour; J-J Meng; Wallace Ip; Mia MacCollin; Nancy Ratner
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authors:  Scott R Plotkin; Jaishri O Blakeley; D Gareth Evans; C Oliver Hanemann; Theo J M Hulsebos; Kim Hunter-Schaedle; Ganjam V Kalpana; Bruce Korf; Ludwine Messiaen; Laura Papi; Nancy Ratner; Larry S Sherman; Miriam J Smith; Anat O Stemmer-Rachamimov; Jeremie Vitte; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

Review 5.  Neurofibromatosis type 2.

Authors:  D G Evans; M Sainio; M E Baser
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

6.  Multiple schwannomas: report of two cases.

Authors:  V K Javalkar; T Pigott; P Pal; G Findlay
Journal:  Eur Spine J       Date:  2007-01-10       Impact factor: 3.134

7.  High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.

Authors:  Teresita Díaz de Ståhl; Caisa M Hansson; Cecilia de Bustos; Kiran K Mantripragada; Arkadiusz Piotrowski; Magdalena Benetkiewicz; Caroline Jarbo; Leif Wiklund; Tiit Mathiesen; Gunnar Nyberg; V Peter Collins; D Gareth Evans; Koichi Ichimura; Jan P Dumanski
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

8.  Schwannomatosis involving peripheral nerves: a case report.

Authors:  Dong Hun Kim; Jung Hwa Hwang; Sung-Tae Park; Ji Hoon Shin
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

9.  Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.

Authors:  Arkadiusz Piotrowski; Jing Xie; Ying F Liu; Andrzej B Poplawski; Alicia R Gomes; Piotr Madanecki; Chuanhua Fu; Michael R Crowley; David K Crossman; Linlea Armstrong; Dusica Babovic-Vuksanovic; Amanda Bergner; Jaishri O Blakeley; Andrea L Blumenthal; Molly S Daniels; Howard Feit; Kathy Gardner; Stephanie Hurst; Christine Kobelka; Chung Lee; Rebecca Nagy; Katherine A Rauen; John M Slopis; Pim Suwannarat; Judith A Westman; Andrea Zanko; Bruce R Korf; Ludwine M Messiaen
Journal:  Nat Genet       Date:  2013-12-22       Impact factor: 38.330

10.  Aberrant axon neurofilaments in schwannomas associated with phacomatoses.

Authors:  Janine Wechsler; Laurent Lantieri; Jacques Zeller; Marie-Catherine Voisin; Nadine Martin-Garcia; Pierre Wolkenstein
Journal:  Virchows Arch       Date:  2003-09-24       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.